Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
07/2012
07/04/2012CN101652351B Pyrimidinyl-piperazines useful as d3/d2 receptor ligands
07/04/2012CN101522641B Process for synthesis of phenoxy diaminopyrimidine derivatives
07/04/2012CN101337943B Azo compound or salts thereof
07/03/2012US8212048 Method of producing aromatic compound
07/03/2012US8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
07/03/2012US8212035 Process for preparation of rosuvastatin calcium field of the invention
07/03/2012US8212034 Process for preparing rosuvastatin calcium
07/03/2012US8212033 Use of substituted quinazoline compounds in treating angiogenesis-related diseases
07/03/2012US8211929 N2-{[3-(1-methylethyl)isoxazol-5-yl]methyl}-N4-[5-(1-methylethyl)-1H-pyrazol-3-yl]-6-[(1-methylpiperidin-3-yl)oxy]pyrimidine-2,4-diamine; IGF1R modulators; Abl mutant inhibitors; antiproliferative agents; to modulate cellular activities like differentiation, programmed cell death, migration, chemoinvas
07/03/2012US8211921 Heterocyclic inhibitors of MEK and methods of use
07/03/2012US8211919 Amide derivatives as rock inhibitors
07/03/2012US8211903 Substituted pyrimido isoquinoline derivatives
07/03/2012US8211902 Quinazolinone derivatives useful as vanilloid antagonists
07/03/2012US8211896 Aryl sulfonamides
07/03/2012US8211513 Liquid-crystalline compounds and liquid-crystalline media
07/03/2012CA2568356C Bicyclic heterocycles as hiv integrase inhibitors
07/03/2012CA2504153C Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
07/03/2012CA2366488C Optimization of ligand affinity for rna targets using mass spectrometry
06/2012
06/28/2012WO2012088192A1 Electronic device including a pyrimidine compound
06/28/2012WO2012087888A2 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (g) quinazoline trisodium salt
06/28/2012WO2012087630A1 Pyridine and pyrimidine compounds for controlling invertebrate
06/28/2012WO2012086768A1 Benzyloxypyrimidine derivative, agricultural/horticultural insecticide comprising derivative and method for using same
06/28/2012WO2012085815A1 Bi-heteroaryl compounds as vps34 inhibitors
06/28/2012WO2012085745A1 Glucagon receptor modulators
06/28/2012WO2012085665A2 Novel processes for preparing triazolo[4,5-d]pyrimidine derivatives and intermediates thereof
06/28/2012WO2012085244A1 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
06/28/2012WO2012085167A1 Metabotropic glutamate receptor modulators
06/28/2012WO2012085166A1 Metabotropic glutamate receptor modulators
06/28/2012WO2012030160A3 Quinoline or quinazoline derivatives with apoptosis inducing activity on cells
06/28/2012WO2012022467A3 Novel benzoquinone derivatives and use thereof as modulators of mitochondrial function
06/28/2012US20120165348 Novel compounds
06/28/2012US20120165343 Glucagon Receptor Modulators
06/28/2012CA2822565A1 Bi-heteroaryl compounds as vps34 inhibitors
06/28/2012CA2822017A1 Glucagon receptor modulators
06/28/2012CA2819510A1 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta(g)quinazoline trisodium salt
06/27/2012EP2468732A1 1H-Quinazoline-2,4-diones
06/27/2012EP2468731A1 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
06/27/2012EP2468727A1 Pyridine and pyrimidine derivatives as MGLUR2 antagonists
06/27/2012EP2467363A1 Process for the manufacture of rosuvastatin calcium using crystalline rosuvastatin ethyl ester
06/27/2012EP2467362A2 Phosphatidylcholine transfer protein inhibitors
06/27/2012EP2467142A2 Heat shock protein binding compounds, compositions, and methods for making and using same
06/27/2012EP2467137A1 Biaryl compounds and methods of use thereof
06/27/2012EP2125735B1 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
06/27/2012EP1719762B1 Novel pyridine derivative and pyrimidine derivative (1)
06/27/2012CN1972688B 4-phenylamino-quinazolin-6-yl-amides
06/27/2012CN102516994A Fluorescence chemical sensors for mercury ion detection and preparation and application method
06/27/2012CN102516183A Method for preparing sulfadoxine and its intermediate
06/27/2012CN102516182A Preparation method for 4-amino-6-alkoxyl pyrimidine compounds
06/27/2012CN102516181A Polymerizable monomers
06/27/2012CN102516162A Method for preparing copper-catalyzed nitro aromatic (heterocyclic) compounds
06/27/2012CN102516122A Environment friendly method for preparing DMF (Dimethyl Formamide) solution of 2-hydroxy-benzonitril, DMF solution of 2-hydroxy-benzonitril and application thereof
06/27/2012CN102516000A Method for synthesizing aryl trifluoromethyl sulphydryl compound
06/27/2012CN102515998A Method for synthesizing 5-cyano pyridine nucleoside derivatives
06/27/2012CN102512422A Composition and method for enhanced delivery of 5,5-diphenyl barbituric acid
06/27/2012CN101857572B 4-aromatic amino pyrimidine derivative and application thereof
06/27/2012CN101663303B Heteroaromatic compounds, the preparation method and the use thereof
06/27/2012CN101535280B Arylsulfonamide compounds
06/27/2012CN101133038B HIV inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines
06/27/2012CN101103000B Carbazole, carboline, and indole derivatives useful in the inhibition of VEGF production
06/26/2012US8207334 Bicyclic pyrimidinones and uses thereof
06/26/2012US8207333 Hydrolysing an ester of rosuvastatin with a base in the presence of an aprotic solvent, converting the salt with a source of calcium, isolating the amorphous rosuvastatin calcium; impurity free; hyperlipidemia, hypercholesterolemia atherosclerosis.
06/26/2012US8207183 Inhibitors of IAP
06/26/2012US8207181 Substituted dihydro, trihydro and tetrahydro cycloalkyloxazolopyrimidinones, preparation and use thereof
06/26/2012US8207153 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
06/26/2012CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor
06/26/2012CA2566609C Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
06/26/2012CA2555804C Polymorphic form of imatinib mesylate and a process for its preparation
06/26/2012CA2438582C Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/21/2012WO2012082857A1 Neprilysin inhibitors
06/21/2012WO2012082853A1 Neprilysin inhibitors
06/21/2012WO2012082817A1 Biarylamide inhibitors of leukotriene production
06/21/2012WO2012081604A1 Composition containing orotic acid, and process for production thereof
06/21/2012WO2012080052A1 Bispyrimidines for electronic applications
06/21/2012WO2012079164A1 Activators of cylindrical proteases
06/21/2012WO2012002741A3 Process for the preparation of hmg-coa reductase inhibitors and intermediates thereof
06/21/2012US20120157484 Tryptophan hydroxylase inhibitors
06/21/2012US20120157482 Compounds and methods
06/21/2012US20120157476 Oxime compounds
06/21/2012US20120157438 Pyranyl aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
06/21/2012US20120157431 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
06/21/2012US20120157426 Mutant-selective egfr inhibitors and uses thereof
06/21/2012US20120157415 New Crystalline Form of Pemirolast
06/21/2012US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors
06/21/2012US20120157383 Neprilysin inhibitors
06/21/2012US20120157306 Substituted Fused Pyrimidinones and Dihydropyrimidinones
06/21/2012US20120156255 Drug eluting patch for the treatment of localized tissue disease or defect
06/21/2012US20120156219 Nitrogen-containing heterocyclic compounds and medicinal use thereof
06/21/2012CA2822071A1 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
06/21/2012CA2819153A1 Neprilysin inhibitors
06/21/2012CA2817368A1 Neprilysin inhibitors
06/20/2012EP2465504A1 Novel 2,3-diamino-quinazolinone derivatives and their medical use
06/20/2012EP2464634A1 Regioselective preparation of 2 -amino-5-trifluoromethylpyrimidine derivatives
06/20/2012EP2464633A1 Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives
06/20/2012EP1960347B1 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors
06/20/2012EP1874733B1 Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators
06/20/2012EP1747205B1 Chiral phosphine ligands, their preparation, catalysts thereof and their use
06/20/2012CN1906183B N-acylsulfonamide apoptosis promoters
06/20/2012CN102510858A Aromatic amine derivative, and organic electroluminescent element comprising same
06/20/2012CN102503933A Chemical process
06/20/2012CN102503899A Crystal of phenylalanine derivative, process for producing the same and use thereof
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 427